Better lipid target achievement for secondary prevention through disease management programs for diabetes mellitus and coronary heart disease in clinical practice in Germany

2015 ◽  
Vol 32 (3) ◽  
pp. 417-426 ◽  
Author(s):  
Anselm K. Gitt ◽  
Frank Sonntag ◽  
Christina Jannowitz ◽  
Achim Weizel ◽  
Barbara Karmann ◽  
...  
2011 ◽  
Vol 57 (6) ◽  
pp. 57-63
Author(s):  
A A Aleksandrov ◽  
S S Kukharenko ◽  
M N Iadrikhinskaia ◽  
O A Shatskaia ◽  
E N Drozdova

The clinical application of thiazolidinediones has an almost 12 year history. The correction of carbohydrate metabolism achieved by the treatment with hiazolidinediones is associated with the reduction of many risk factors of coronary heart disease and the improvement of prognosis for the patients presenting with type 2 diabetes mellitus. The possible mechanisms underlying complications encountered in the clinical practice in connection with the use of thiazolidinediones are discussed.


2011 ◽  
Vol 14 (1) ◽  
pp. 61-68
Author(s):  
Victor Yur'evich Kalashnikov ◽  
Irina Ziyatovna Bondarenko ◽  
Alexander Borisovich Kuznetsov ◽  
Diana Dzhemalovna Beshlieva ◽  
Sergey Anatol'evich Terekhin ◽  
...  

Introduction into clinical practice of coronary angioplasty has provided new possibilities for treatment of coronary heart disease (CHD) in patientswith diabetes mellitus. The indications for endovascular interventions and principles of coronary stenting in such patients are described in this article.


Sign in / Sign up

Export Citation Format

Share Document